CTLA4 and neoplasm: Inhibitory immune checkpoint molecules, including PD-1, CTLA4, and LAG3, are abundantly expressed on the surface of tumor-infiltrating lymphocytes, thus causing susceptibility to inhibitory signals from the TME [22].